 NEW YORK, NY, Feb. 03, 2021 GLOBE NEWSWIRE -- Enzo Biochem, Inc. NYSE:ENZ Enzo or the Company, a leading biosciences and diagnostics company, today announced the recent issuance of U.S. Patent No. 10,899,827 entitled Antibodies Specific for Sulfation Sites of Sclerostin. 